Free Trial
NASDAQ:CLPT

ClearPoint Neuro (CLPT) Stock Price, News & Analysis

ClearPoint Neuro logo
$11.52 -0.40 (-3.36%)
As of 02:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About ClearPoint Neuro Stock (NASDAQ:CLPT)

Key Stats

Today's Range
$11.22
$11.91
50-Day Range
$10.00
$13.93
52-Week Range
$9.46
$19.22
Volume
358,130 shs
Average Volume
316,078 shs
Market Capitalization
$322.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.67
Consensus Rating
Buy

Company Overview

ClearPoint Neuro Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
34th Percentile Overall Score

CLPT MarketRank™: 

ClearPoint Neuro scored higher than 34% of companies evaluated by MarketBeat, and ranked 644th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ClearPoint Neuro has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    ClearPoint Neuro has only been the subject of 1 research reports in the past 90 days.

  • Read more about ClearPoint Neuro's stock forecast and price target.
  • Earnings Growth

    Earnings for ClearPoint Neuro are expected to grow in the coming year, from ($0.66) to ($0.59) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ClearPoint Neuro is -14.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ClearPoint Neuro is -14.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ClearPoint Neuro has a P/B Ratio of 12.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    9.06% of the float of ClearPoint Neuro has been sold short.
  • Short Interest Ratio / Days to Cover

    ClearPoint Neuro has a short interest ratio ("days to cover") of 5.8.
  • Change versus previous month

    Short interest in ClearPoint Neuro has recently increased by 14.01%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    ClearPoint Neuro does not currently pay a dividend.

  • Dividend Growth

    ClearPoint Neuro does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.06% of the float of ClearPoint Neuro has been sold short.
  • Short Interest Ratio / Days to Cover

    ClearPoint Neuro has a short interest ratio ("days to cover") of 5.8.
  • Change versus previous month

    Short interest in ClearPoint Neuro has recently increased by 14.01%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    ClearPoint Neuro has a news sentiment score of -0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for ClearPoint Neuro this week, compared to 2 articles on an average week.
  • Search Interest

    Only 3 people have searched for CLPT on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added ClearPoint Neuro to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ClearPoint Neuro insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $415,173.00 in company stock.

  • Percentage Held by Insiders

    Only 6.97% of the stock of ClearPoint Neuro is held by insiders.

  • Percentage Held by Institutions

    Only 30.08% of the stock of ClearPoint Neuro is held by institutions.

  • Read more about ClearPoint Neuro's insider trading history.
Receive CLPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter.

CLPT Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
ClearPoint Neuro Reports Record Q2 Revenue Growth
ClearPoint Neuro, Inc. (CLPT) Q2 2025 Earnings Call Transcript
ClearPoint Neuro Q2 2025 Earnings Preview
ClearPoint Neuro (CLPT) Projected to Post Earnings on Tuesday
See More Headlines

CLPT Stock Analysis - Frequently Asked Questions

ClearPoint Neuro's stock was trading at $15.38 at the beginning of the year. Since then, CLPT stock has decreased by 25.7% and is now trading at $11.42.

ClearPoint Neuro, Inc. (NASDAQ:CLPT) announced its earnings results on Tuesday, August, 12th. The company reported ($0.21) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by $0.01. The company earned $9.22 million during the quarter, compared to analyst estimates of $9.20 million. ClearPoint Neuro had a negative net margin of 66.15% and a negative trailing twelve-month return on equity of 89.64%.
Read the conference call transcript
.

ClearPoint Neuro's top institutional investors include Geode Capital Management LLC (2.23%), Lane Generational LLC (0.92%), Taylor Frigon Capital Management LLC (0.64%) and Conway Capital Management Inc. (0.59%). Insiders that own company stock include Joseph Michael Burnett, Joseph Burnett and Timothy T Richards.
View institutional ownership trends
.

Shares of CLPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ClearPoint Neuro investors own include Arista Networks (ANET), NVIDIA (NVDA), CrowdStrike (CRWD), Axon Enterprise (AXON), Advanced Micro Devices (AMD), Cadence Design Systems (CDNS) and Broadcom (AVGO).

Company Calendar

Last Earnings
8/12/2025
Today
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CLPT
CIK
1285550
Employees
110
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$9.00
Potential Upside/Downside
+73.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.91 million
Net Margins
-66.15%
Pretax Margin
-64.50%
Return on Equity
-89.64%
Return on Assets
-60.91%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.53
Quick Ratio
2.57

Sales & Book Value

Annual Sales
$33.59 million
Price / Sales
9.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.92 per share
Price / Book
12.33

Miscellaneous

Outstanding Shares
27,989,000
Free Float
26,038,000
Market Cap
$317.59 million
Optionable
Optionable
Beta
0.85

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:CLPT) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners